Group 1 - The company, Shanghai Aladdin Biochemical Technology Co., Ltd., plans to invest in Shanghai Yamei Biomedical Technology Co., Ltd. through capital increase and share acquisition, with a total investment of 41.17 million RMB [2] - The investment will be executed in two steps: first, a capital increase of 24.7 million RMB for a 15% stake at a valuation of 140 million RMB; second, acquiring a 10% stake from existing shareholders for 16.47 million RMB [2] - Upon completion of the investment, the company will hold a total of 25% equity in Yamei Biomedical [2] Group 2 - Yamei Biomedical has completed its business registration, with a registered capital of 1.433154 million RMB and established on March 18, 2019 [3] - The company operates in various fields including technology services, health consulting, cell technology research, and biomedical engineering [3] - The legal representative of Yamei Biomedical is Wu Jun, and it is classified as a limited liability company [3]

证券代码：688179 证券简称：阿拉丁 公告编号：2025-053 （公告编号：2025-025）。 二、交易进展 近日，雅酶生物已完成工商登记手续，工商登记信息如下： 公司名称：上海雅酶生物医药科技有限公司 转债代码：118006 转债简称：阿拉转债 上海阿拉丁生化科技股份有限公司 关于对外投资上海雅酶生物医药科技有限公司的进 展暨完成工商登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、交易概述 上海阿拉丁生化科技股份有限公司（以下简称"阿拉丁"或"公司"）拟以 增资、认购老股方式对上海雅酶生物医药科技有限公司（以下简称"目标公司" 或"雅酶生物"）进行投资，认购目标公司一定的新增注册资本及认购老股（"本 次投资"）。本次投资分两步走，第一步由公司先按 14,000 万元的估值向目标公 司增资 2,470 万元，取得目标公司增资后 15%的股权；第二步由公司按 16,470 万元的估值受让原股东持有的目标公司（增资后）10%的股权，股权转让总对价 为 1,647 万元。本次投资下投资方合计出资 4,1 ...

一、交易概述 | 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-053 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于对外投资上海雅酶生物医药科技有限公司的进 展暨完成工商登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 主要股东： | 股东名称/姓名 | 出资比例 | | --- | --- | | 吴军 | 41.1074% | | 上海阿拉丁生化科技股份有限公司 | 25.0000% | | 上海熠廷企业管理合伙企业（有限合伙） | 10.4700% | | 上海佑登企业管理合伙企业（有限合伙） | 9.2325% | | 上海卉烨企业管理合伙企业（有限合伙） | 8.9550% | | 上海洛哈企业管理合伙企业（有限合伙） | 5.2351% | | 合计 | 100.0000% | 特此公告。 上海阿拉丁生化科技股份有限公司 董事会 上海阿拉丁生化科技股份有限公司（以下简称"阿拉丁"或 ...

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-052 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于设立合资公司的进展暨完成工商登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、交易概述 法定代表人：李传宝 上海阿拉丁生化科技股份有限公司（以下简称"阿拉丁"或"公司"）广东 菲鹏生物有限公司（以下简称"菲鹏生物"）于 2025 年 1 月 3 日签署《原料试剂 孵化项目交易框架协议》，通过原料、试剂及解决方案定制化开发及资产、技术 许可及服务转让等一系列交易，双方有意将共同新发起设立的项目公司孵化成为 具备原料和试剂及解决方案供应、原料和试剂生产及自主研发能力的公司。具体 内容详见公司于 2025 年 1 月 7 日在上海证券交易所网站(www.sse.com.cn)披露 的《上海阿拉丁生化科技股份有限公司关于自愿披露签订战略合作框架协议暨设 立合资公司的公告》（公告编号：2025-00 ...

Core Viewpoint - Aladdin (688179.SH) plans to bid for an 81.96% stake in Kasma Holdings from the Chinese Academy of Sciences Holdings Co., Ltd. with a starting price of 202 million yuan, aiming to enhance market competitiveness through resource integration and sales channel expansion [1][3]. Group 1: Company Overview - Kasma Holdings, established in 2016, focuses on technology services, investment consulting, and research resource promotion, with projected revenues exceeding 160 million yuan in both 2023 and 2024, and net profits of 54.02 million yuan and 25.67 million yuan respectively [3]. - Aladdin is a domestic supplier of research reagents, covering high-end chemicals and life sciences through its "Aladdin" brand, with a projected sales revenue of 534 million yuan in 2024, representing a year-on-year growth of 32.44% [3]. Group 2: Auction Details - The auction for Kasma Holdings will consist of a free bidding period from July 7, 10:00 to 10:10, followed by a timed bidding period, with the final outcome remaining uncertain [3]. - If the bidding is successful, Aladdin will further strengthen its research service ecosystem; if unsuccessful, the company emphasizes that its existing business will not be significantly affected [3].

Group 1 - The company held its 24th meeting of the 4th Supervisory Board on July 4, 2025, to discuss important matters [2][3] - The Supervisory Board approved the proposal to participate in the auction for 81.96% equity of Kasma Holdings Co., Ltd. held by the Chinese Academy of Sciences Holdings Co., Ltd. [3][4] - The auction aims to expand the company's sales channels, integrate downstream resources, and enhance market competitiveness and profitability [3][15] Group 2 - The auction is for 81.96% equity of Kasma Holdings with a starting price of 201.989109 million yuan [8][10] - The auction will take place at the Beijing Property Exchange, with a two-phase bidding process scheduled for July 7, 2025 [14] - The transaction does not constitute a related party transaction or a major asset restructuring as defined by relevant regulations [10][12] Group 3 - The Chinese Academy of Sciences Holdings Co., Ltd. is the seller, a state-owned enterprise with a registered capital of 5.06703 billion yuan [11] - Kasma Holdings Co., Ltd. has a registered capital of 50 million yuan and engages in various investment and consulting activities [13] - The first major shareholder of Kasma Holdings is the Chinese Academy of Sciences Holdings, which holds 81.96% of the equity [13]

Mergers and Acquisitions - Aladdin announced its participation in the auction for 81.96% equity of Kasma Holdings, with a transfer base price of 202 million yuan, aiming to expand sales channels and integrate downstream resources [1] - *ST Baoshi received approval from the Ningxia State-owned Assets Supervision and Administration Commission for the acquisition of 100% equity of Ningxia Electric Power Investment New Energy Co., Ltd. through major asset replacement and cash payment [2] - Guotou Zhonglu disclosed a transaction plan to acquire 100% shares of China Electronic Engineering Design Institute through share issuance, with the specific transaction price yet to be determined [3] Shareholding Changes - MaiPu Medical announced that shareholder Tang Ying plans to reduce holdings by no more than 1% of the company's shares, totaling up to 665,100 shares [4] - Yue Wannianqing disclosed that a 10% shareholder, Hehe Investment, plans to reduce holdings by no more than 6% of the company's shares, totaling up to 4.8 million shares [5] - *ST Huawang announced that shareholder Wu Qun plans to reduce holdings by no more than 1.76% of the company's shares, totaling up to 15,414,300 shares [6] Regulatory Issues - Liuhua Co. received an administrative regulatory decision from the Guangxi Securities Regulatory Bureau due to issues related to accounting irregularities and failure to fulfill obligations regarding the integrity of appointed directors and supervisors [7] - *ST Huike was investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8][9] - Tuisijingang announced that two vice presidents were arrested for violating important information disclosure laws, but stated that this would not impact the company's normal operations [10]

Financial Performance - Whirlpool expects a net profit of approximately 205 million yuan for the first half of 2025, an increase of about 174 million yuan or approximately 559% year-on-year [2] - Chipmotion Technology anticipates a net profit between 138 million to 169 million yuan for the first half of 2025, representing a year-on-year growth of approximately 144.46% to 199.37% [2] Mergers and Acquisitions - China Shipbuilding's absorption merger with China Shipbuilding Industry Corporation has been approved by the Shanghai Stock Exchange, pending further regulatory approvals [3] - Guotou Zhonglu plans to acquire 100% of China Electronic Engineering Design Institute through a share issuance, which constitutes a major asset restructuring [4] Shareholder Actions - Aotewei's actual controllers plan to transfer 4.99% of the company's shares, totaling 15.75 million shares, due to personal funding needs [5] - Yaguang Technology's chairman has been placed under detention, but the company's operations remain normal [5] Industry Developments - Ningbo Port expects a 9.8% year-on-year increase in container throughput for the first half of 2025 [8] - Three Trees anticipates a net profit growth of 80.94% to 119.04% for the first half of 2025 [8] - Zhuhai Group expects a net profit increase of 50.97% to 75.23% for the first half of 2025 [8] Project Wins - Sanxing Medical's subsidiary has pre-qualified for a 306 million yuan project with Southern Power Grid [8] - Hopu Co., Ltd. has jointly won a 449 million yuan shared energy storage demonstration project [8] - Hongsheng Huayuan's subsidiary has pre-qualified for an 1.127 billion yuan project with Southern Power Grid [8]

Core Viewpoint - The company Aladdin (688179) is participating in the auction for an 81.96% stake in Kasma Holdings, which is being sold by the Chinese Academy of Sciences Holdings, with a starting price of 202 million yuan [1] Group 1: Company Overview - Aladdin is a comprehensive manufacturer of research reagents, covering high-end chemicals, life sciences, analytical chromatography, and materials science, while also offering a small amount of laboratory consumables [2] - The company has developed its own "Aladdin" brand for research reagents and "Chip Silicon Valley" brand for laboratory consumables, primarily relying on its e-commerce platform for online sales [2] Group 2: Financial Performance - Aladdin's sales revenue for 2022, 2023, and 2024 was 378 million, 403 million, and 534 million yuan respectively, showing a year-on-year increase [2] - In 2024, the company achieved a revenue growth of 32.44% and a net profit of 98.76 million yuan, up 15.07% year-on-year [2] - In the first quarter of 2025, Aladdin reported a revenue of 130 million yuan, a 32.2% increase year-on-year, with a net profit of 24.18 million yuan, up 41.35% year-on-year [2] Group 3: Industry Insights - According to the National Bureau of Statistics, China's R&D expenditure for 2024 is projected to be 3.613 trillion yuan, an 8.3% increase from the previous year, indicating stable growth in the sector [2] - The R&D expenditure intensity (R&D expenditure as a percentage of GDP) is 2.68%, which is an increase of 0.1 percentage points from the previous year [2] - The increase in R&D funding is expected to drive the sales of consumables like reagents, suggesting a long-term growth potential for the industry [2] Group 4: Strategic Moves - The transaction aims to broaden the company's sales channels, integrate downstream resources, and enhance market competitiveness and profitability, benefiting both the company and its investors [3] - The auction process consists of two bidding periods: a free bidding period and a timed bidding period, with specific time frames outlined for each [3]

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-051 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于参与竞拍喀斯玛控股有限公司股权的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 根据北京产权交易所公开披露的产权转让信息，中国科学院控股有限公 司（以下简称"中科院控股"）公开挂牌出售其持有的喀斯玛控股有限 公司（以下简称"喀斯玛控股"）81.96%的股权（以下简称"标的股权"）， 转让底价 20,198.9109 万元。 2025 年 7 月 4 日，上海阿拉丁生化科技股份有限公司（以下简称"公司"） 召开第四届董事会第四十次会议及第四届监事会第二十四次会议，审议 通过了《关于参与竞拍中国科学院控股有限公司持有的喀斯玛控股有限 公司 81.96%的股权的议案》，同意公司参与中科院控股所持标的股份的 竞拍（以下简称"本次交易"）。 本次交易不构成关联交易，亦不构成《上市公司重大资产重组 ...